Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Moderate — the lead ingredient has meta-analyzed randomized trial support, but the supporting botanicals are still preclinical
What Nerve Armor Claims To Be
Nerve Armor is sold as a daily supplement for people dealing with tingling, burning, and numbness in the hands and feet. The marketing frames the problem as overactive immune cells in nervous tissue — described on the sales page as “termite cells,” which is a folksy way of talking about activated microglia — and positions the formula as a way to calm that activity.
Strip away the branding and the underlying idea is defensible. Neuroinflammation as a driver of chronic nerve pain is a mainstream research area, not a fringe theory. The question is whether the specific ingredients do anything about it in humans.
What’s Actually In It
Nerve Armor is built around three named ingredients:
- Palmitoylethanolamide (PEA) — a fatty acid amide the body produces naturally
- Gotu kola (Centella asiatica) extract
- Corydalis extract
A caveat before you read further: the product page does not publish a full Supplement Facts panel with per-ingredient doses. That matters here more than usual, because the PEA research below is dose-specific — the trials that worked used defined amounts, and you cannot tell from the marketing whether this formula matches them. Ask for the panel before you buy.
What The Research Shows
According to PubMed, the evidence divides sharply between the lead ingredient and the two botanicals behind it.
PEA has the best evidence of anything in this formula. A 2025 meta-analysis pooled 18 randomized clinical trials covering 1,196 patients and found significant pain reduction with PEA at 6 weeks, 8 weeks, and 24–26 weeks, along with improved quality of life. Critically for this product, the effect held specifically for neuropathic pain (standardized mean difference −0.97), not just general aches. DOI
A second, independent meta-analysis reached the same conclusion. Restricting itself to double-blind randomized trials only — a stricter filter — a 2023 systematic review of 11 trials and 774 patients found PEA reduced pain scores versus comparators, with no major side effects attributed to PEA in any included study. Two separate research teams, different inclusion criteria, same direction of effect. DOI
It has been tested directly in diabetic nerve pain. In a quadruple-blinded placebo-controlled trial, 70 participants with diabetes-related peripheral neuropathic pain took 600 mg of PEA or placebo daily for eight weeks. The PEA group had significantly reduced pain and pain interference, better sleep, lower interleukin-6 and C-reactive protein, and improved depression scores. This is the trial closest to what Nerve Armor is marketed for. DOI
But PEA is not universal, and one good trial found nothing. A randomized, double-blind, placebo-controlled multicenter study gave ultramicronized PEA to 73 people with neuropathic pain from spinal cord injury over 12 weeks. There was no difference in pain intensity between PEA and placebo, and no effect on spasticity, insomnia, or mood. Nerve pain from a severed spinal cord is a different mechanism than nerve pain from metabolic damage, and PEA appears to help with one and not the other. DOI
Gotu kola’s nerve claims rest on animal work, not human trials. In rats given Centella asiatica ethanolic extract in their drinking water after nerve crush injury, researchers observed faster functional recovery and more myelinated axons of larger calibre than controls — genuine evidence that something in the plant accelerates axon regrowth. But this was rats, at roughly 300 mg/kg, and the cell-culture arm of the same paper showed the effect depended on the extract type. DOI
A second gotu kola study points the same way, also in animals. A standardized Centella extract reduced mechanical hyperalgesia and allodynia in mice with chronic constriction injury of the infraorbital nerve, and downregulated CGRP in the trigeminal ganglion. The authors were explicit that human trials in neuropathic pain still need to be done. DOI
Corydalis has a long analgesic tradition and mechanistic backing, but not for nerve pain specifically. Recent work on Corydalis rhizoma in a rat model found it reduced pain behavior and inflammatory signaling through the FAK/PI3K-AKT/NF-κB pathway. That is a real anti-inflammatory mechanism, but the model was primary dysmenorrhea, and it does not transfer automatically to peripheral neuropathy. DOI
The Honest Verdict
What holds up: PEA is a genuinely well-supported ingredient. Two independent meta-analyses of randomized trials both found meaningful pain reduction, the safety record across those trials is clean, and there is a directly relevant 600 mg RCT in diabetic peripheral neuropathy. If you were going to take one thing off this label, that is the one with the receipts.
What doesn’t: The gotu kola and corydalis case is preclinical. Rodent nerve-crush recovery and mouse allodynia are encouraging starting points, not proof of a human effect, and the researchers who ran those studies said so themselves. The spinal cord injury trial is also a useful corrective — same compound, rigorous design, no benefit. Nerve pain has many causes and PEA does not address all of them. And the undisclosed dosing is a real weakness: a formula containing PEA at 100 mg is not the formula that was studied at 600 mg.
Who this makes sense for: Someone with diagnosed peripheral nerve discomfort — most often metabolic or compression-related — who has talked to a doctor, understands this is an adjunct rather than a replacement for treatment, and is willing to give it six to eight weeks, which is roughly when the trial effects appeared.
Who should skip it: Anyone expecting fast relief, anyone with nerve pain from spinal cord injury given the negative trial, and anyone who would use this instead of getting undiagnosed numbness or tingling looked at. New neuropathy symptoms are a reason to see a physician, not a reason to shop.
Check current pricing and availability
View Nerve Armor on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed:
- Viña I, López-Moreno M. Nutr Rev. 2025;83(7):e1604-e1618. DOI
- Lang-Illievich K, et al. Nutrients. 2023;15(6):1350. DOI
- Pickering E, et al. Inflammopharmacology. 2022;30(6):2063-2077. DOI
- Andresen SR, et al. Pain. 2016;157(9):2097-2103. DOI
- Soumyanath A, et al. J Pharm Pharmacol. 2005;57(9):1221-9. DOI
- Buapratoom A, et al. J Ethnopharmacol. 2021;283:114737. DOI
- Zhang J, et al. J Ethnopharmacol. 2025;353(Pt B):120420. DOI